title: Gender differences in pressure-natriuresis and renal autoregulation: role of the Angiotensin type 2 receptor.
abstract: Sexual dimorphism in arterial pressure regulation has been observed in humans and animal models. The mechanisms underlying this gender difference are not fully known. Previous studies in rats have shown that females excrete more salt than males at a similar arterial pressure. The renin-angiotensin system is a powerful regulator of arterial pressure and body fluid volume. This study examined the role of the angiotensin type 2 receptor (AT₂R) in pressure-natriuresis in male and female rats because AT₂R expression has been reported to be enhanced in females. Renal function was examined at renal perfusion pressures of 120, 100, and 80 mm Hg in vehicle-treated and AT₂R antagonist-treated (PD123319; 1 mg/kg/h) groups. The pressure-natriuresis relationship was gender-dependent such that it was shifted upward in female vs male rats (P < 0.001). AT₂R blockade modulated the pressure-natriuresis relationship, shifting the curve downward in male (P < 0.01) and female (P < 0.01) rats to a similar extent. In females, AT₂R blockade also reduced the lower end of the autoregulatory range of renal blood flow (P < 0.05) and glomerular filtration rate (P < 0.01). Subsequently, the renal blood flow response to graded angiotensin II infusion was also measured with and without AT₂R blockade. We found that AT₂R blockade enhanced the renal vasoconstrictor response to angiotensin II in females but not in males (P < 0.05). In conclusion, the AT₂R modulates pressure-natriuresis, allowing the same level of sodium to be excreted at a lower pressure in both genders. However, a gender-specific role for the AT₂R in renal autoregulation was evident in females, which may be a direct vascular AT₂R effect.
authors.affiliation: Department of Physiology, Monash University, Victoria, Australia, 3800.
authors.forename: Lucinda M
authors.initials: LM
authors.lastname: Hilliard
authors.forename: Mehdi
authors.initials: M
authors.lastname: Nematbakhsh
authors.forename: Michelle M
authors.initials: MM
authors.lastname: Kett
authors.forename: Elleesha
authors.initials: E
authors.lastname: Teichman
authors.forename: Amanda K
authors.initials: AK
authors.lastname: Sampson
authors.forename: Robert E
authors.initials: RE
authors.lastname: Widdop
authors.forename: Roger G
authors.initials: RG
authors.lastname: Evans
authors.forename: Kate M
authors.initials: KM
authors.lastname: Denton
mesh_terms: D000704:Analysis of Variance; D000804:Angiotensin II / Q000494:pharmacology; D057912:Angiotensin II Type 2 Receptor Blockers / Q000494:pharmacology; D000818:Animals; D001835:Body Weight / Q000502:physiology; D005260:Female; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007668:Kidney / Q000033:anatomy & histology / Q000502:physiology*; D008297:Male; D009318:Natriuresis / Q000187:drug effects / Q000502:physiology*; D009929:Organ Size; D011312:Pressure; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D044139:Receptor, Angiotensin, Type 2 / Q000502:physiology*; D012079:Renal Circulation / Q000502:physiology; D012737:Sex Factors; D014662:Vasoconstrictor Agents / Q000494:pharmacology
chemical_list: D057912:Angiotensin II Type 2 Receptor Blockers; D007093:Imidazoles; D011725:Pyridines; D044139:Receptor, Angiotensin, Type 2; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; C073402:PD 123319